Psilocybin Shows Promise in Preventing Chemotherapy-Induced Neuropathy in Mice

A preclinical study in mice suggests psilocybin may prevent chemotherapy-induced peripheral neuropathy, a common side effect affecting over 60% of patients on platinum-based treatments. The finding is at an early animal-model stage; human efficacy and safety remain unproven. If replicated, it could open a new therapeutic avenue for a debilitating condition with limited options.